title: Testicular function in patients with type 1 diabetes treated with high-dose CY and autologous hematopoietic SCT.
authors.forename: A M O
authors.initials: AM
authors.lastname: Leal
authors.forename: M C
authors.initials: MC
authors.lastname: Oliveira
authors.forename: C E B
authors.initials: CE
authors.lastname: Couri
authors.forename: D A
authors.initials: DA
authors.lastname: Moraes
authors.forename: A-Bpl
authors.initials: AB
authors.lastname: Stracieri
authors.forename: F
authors.initials: F
authors.lastname: Pieroni
authors.forename: R D A
authors.initials: RD
authors.lastname: Soares
authors.forename: G N
authors.initials: GN
authors.lastname: Barros
authors.forename: B P
authors.initials: BP
authors.lastname: Simões
authors.forename: M C
authors.initials: MC
authors.lastname: Foss
authors.forename: J C
authors.initials: JC
authors.lastname: Voltarelli
mesh_terms: D000293:Adolescent; D000328:Adult; D019540:Area Under Curve; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D012189:Retrospective Studies; D013737:Testis / Q000378:metabolism*; D013997:Time Factors; D014182:Transplantation, Autologous
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide